Genting Singapore - CGS-CIMB Research 2022-05-13: Time To Step Up Its Game

Genting Singapore - Time To Step Up Its Game

GENTING SINGAPORE LIMITED (SGX:G13) | SGinvestors.ioGENTING SINGAPORE LIMITED (SGX:G13)
  • Genting Singapore (SGX:G13)'s tevenue of S$314.5m in 1Q22 was characterised by a recovery of both gaming and non-gaming revenues (+13.2% y-o-y/+25.8% y-o-y).
  • 1Q22 adjusted EBITDA of S$124.8m came in below expectations at 15.8%/18.0% of our/consensus FY22 estimates on higher utilities cost and slower recovery.
  • Expectations of subsequent recovery dampened as strict COVID-19 restrictions from key source markets are unlikely to be lifted soon.
  • We cut our FY22-24F earnings per share forecast for Genting Singapore (SGX:G13) by 4-31% as we push back the expected return of tourists in FY22F and factor in higher utilities expenses in FY22F-24F. We also lower our target price for Genting Singapore (SGX:G13) to S$0.92, pegged at 9x FY23F EV/EBITDA , 0.5 standard deviation below its 5-year historical mean.



Above is the excerpt from research report by CGS-CIMB.
Clients of CGS-CIMB may access the full report in PDF @ https://www.itradecimb.com.sg/.



TAY Wee Kuang CGS-CIMB Research | https://www.cgs-cimb.com 2022-05-13
SGX Stock Analyst Report ADD MAINTAIN ADD 0.92 DOWN 0.960




Previous report by CGS-CIMB:
2022-02-18 Genting Singapore - Hopeful Of Better Recovery In FY23

Target prices by 2 other brokers at Genting Singapore Target Prices.
Listing of broker reports at Genting Singapore Analyst Report.

Relevant links:
Genting Singapore Share Price History,
Genting Singapore Announcements,
Genting Singapore Dividends & Corp Actions,
Genting Singapore News Articles





Advertisement










Stock / REIT Search

Advertisement

Advertisement